General report on the European Union concerted action workshop on 11q23, London, UK, May 1997.
Affiliation
Department of Haematology, The Royal Free Hospital School of Medicine, London, UK.Issue Date
1998-05
Metadata
Show full item recordAbstract
Seventeen cytogenetic laboratories in eight European countries contributed karyotypic, hematological, clinical and follow-up data from 550 patients with an acquired abnormality of 11q23. The patients had acute lymphoblastic leukemia (254), acute myeloid leukemia (250), unspecified, undifferentiated, biphenotypic acute leukemia or myeloproliferative disorder (18 cases together), or myelodysplastic syndrome (MDS) (28). The patients were classified by cytogenetic subgroup as t(4;11) (183 cases), t(6;11) (30) cases), t(9;11) (125 cases), t(10;11) (20 cases), t(11;19) (53 cases), 'other' abnormalities of 11q23 (82 cases) and del(11)(q23) (57 cases). Manuscripts were prepared on each cytogenetic subgroup, on MDS, on secondary hematological malignancies (40 cases) and on 11q23-translocation derivatives. For each subgroup the following aspects were investigated: associated clinical features, additional karyotypic change, distribution between hematological subtypes and between different age groups, prognosis at different age groups, and the impact of bone marrow transplantation on survival. The Workshop confirmed some previous findings from smaller studies, challenged others, identified new chromosomal partners and threw new light on less well documented aspects of 11q23 malignancies. The large number of cases investigated in a coordinated manner gives authoritative support to the findings. The Workshop thus demonstrates the value of collaborative European studies in the cytogenetics of malignancy.Citation
General report on the European Union concerted action workshop on 11q23, London, UK, May 1997. 1998, 12 (5):776-8 LeukemiaJournal
LeukemiaPubMed ID
9593280Type
ArticleLanguage
enISSN
0887-6924Collections
Related articles
- Hematological malignancies with t(9;11)(p21-22;q23)--a laboratory and clinical study of 125 cases. European 11q23 Workshop participants.
- Authors: Swansbury GJ, Slater R, Bain BJ, Moorman AV, Secker-Walker LM
- Issue date: 1998 May
- Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. EU Concerted Action 11q23 Workshop.
- Authors: Secker-Walker LM, Moorman AV, Bain BJ, Mehta AB
- Issue date: 1998 May
- Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects. European 11q23 Workshop participants.
- Authors: Harbott J, Mancini M, Verellen-Dumoulin C, Moorman AV, Secker-Walker LM
- Issue date: 1998 May
- Hematologic malignancies with t(4;11)(q21;q23)--a cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases. European 11q23 Workshop participants.
- Authors: Johansson B, Moorman AV, Haas OA, Watmore AE, Cheung KL, Swanton S, Secker-Walker LM
- Issue date: 1998 May
- [Cytogenetics and clinical studies of hematologic malignancies with 11q23 abnormalities in China].
- Authors: Guo Y, Xue Y, Xie X, Wu D, Li J, Lu D, Jiang F, Geng M
- Issue date: 2000 Apr